Nguyen AnhCo
President and CEO
Nguyen AnhCo has filed 5 SEC Form 4 filings (9 transaction rows) across 1 company, with disclosures dating back to 2025. 5 of those filings fall inside the rolling window. Most recent filing: Aug 26, 2026.
On the most recent filing, Nguyen AnhCo is listed as President and CEO at Atara Biotherapeutics, Inc. Inside the rolling window, Nguyen AnhCo reported no open-market purchases and 4 open-market sales totaling $142K in ATRA. The largest disclosed transaction in the window is a sale of 5,241 ATRA shares on May 18, 2026, worth $48K.
Companies traded
Other insiders at ATRA
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$142K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Nguyen AnhCo made?
Nguyen AnhCo has filed 5 SEC Form 4 filings (9 transaction rows) across 1 company since 2025.
Which companies does Nguyen AnhCo trade?
Nguyen AnhCo has filed SEC Form 4 disclosures for 1 company, including ATRA.
When was Nguyen AnhCo's most recent SEC Form 4 filing?
Nguyen AnhCo's most recent SEC Form 4 filing on Tracefour is dated Aug 26, 2026.
What is Nguyen AnhCo's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Nguyen AnhCo is listed as President and CEO.
What is Nguyen AnhCo's total buy and sell value in the current window?
Inside the rolling retention window, Nguyen AnhCo bought $0 and sold $142K based on SEC Form 4 filings.
What was Nguyen AnhCo's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 5,241 ATRA shares on 2026-05-18, worth $48K, per SEC Form 4 filings.